Helping you make cancer patient care your only priority.

Value-Based Cancer Care Support

Thriving in a value-based care environment requires changes to virtually every area of an oncology practice, including the patient experience. Practices in The US Oncology Network provide a variety of non-medical support services to help patients and their families including survivorship, financial counseling, patient assistance programs and advance care planning.

We provide tools that empower practices to succeed in this transformation. Our expertise and comprehensive solutions have been tested and proven in a value-based care environment – ultimately increasing patient satisfaction with their cancer care experience.


Learn More

Cutting-Edge Cancer Clinical Trials

Our world-renowned clinical research program is one of the largest community-based oncology research programs in the U.S. We enable practices to offer patients access to the latest cancer clinical trial options in their local communities, providing the opportunity for better outcomes while contributing to the advancement of cancer treatment.

  • 88,000 patients enrolled in cancer clinical trials to date
  • Contributed to more than 100 FDA-approved cancer therapies
  • Hundreds of research programs enrolling patients at any given time
  • Accelerated enrollment for cancer clinical trials with highly targeted or rare patient populations

Search Clinical Trials

Upcoming Clinical Trials

Breast Cancer - USOR: 23107

A Phase 3 Randomized, Open-Label Study of OP-1250 Monotherapy vs Standard of Care for the Treatment of ER+, HER2- Advanced or Metastatic Breast Cancer Following Endocrine and CDK4/6 inhibitor Therapy (OPERA-01) (OP-1250-301)

ClinicalTrials.gov ID

NCT06016738

Colon Cancer - USOR: 24199

A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with Telisotuzumab Adizutecan in Subjects with Metastatic Colorectal Cancer (AndroMETa-CRC-533) (M24-533)

ClinicalTrials.gov ID

NCT06820463

Lung Cancer - USOR: 24312

An open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab as consolidation therapy following chemoradiotherapy in limited-stage small-cell lung cancer (TIGOS-LS) (CA245-0004)

ClinicalTrials.gov ID

NCT06773910

Lung Cancer - USOR: 24110

MK3475-U01 Master Study: A Phase 1/2, Umbrella Study with Rolling Arms of Investigational Agents, Pembrolizumab, and Chemotherapy, Alone or in Combination, in Participants with Non-small Cell Lung Cancer (NSCLC): MK3475- 01E Sub Study: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID

NCT06788912

Ovarian Cancer - USOR: 24187

Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment With or Without Bevacizumab Versus Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)

ClinicalTrials.gov ID

NCT06824467

Prostate Cancer - USOR: 23047

An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen (PSMA) positiveOligometastatic Prostate Cancer (OMPC) (CAAA617D12302)

ClinicalTrials.gov ID

NCT05939414

Community of Cancer Patient Care Experts

Good things happen when great minds come together, and that’s why we provide a variety of ways for our physicians to connect. Physicians collaborate with their colleagues through physician committees where they determine new ways to lead and guide The US Oncology Network and to shape the future of value-based cancer care. They also interact with one another digitally through My Workspace where more than 1,400 physicians in The Network share ideas and collaborate on complex cases. Additionally, every year we host network-wide conferences and meetings covering a variety of topics to keep physicians abreast of new developments in cancer patient care.


"I have access to a community of physicians and experts going through similar challenges. I am able to reach out to discuss difficult cases; to strategize and expedite solutions."

Rufus Collea, M.D.
New York Oncology Hematology

Patient Advocacy

The US Oncology Network actively advocates regulatory and legislative solutions on behalf of cancer patients, both on the federal and state level, to improve care and to combat proposals that can negatively impact patients. Our highly skilled political experts are dedicated to making sure the voices and concerns of cancer patients are heard in today’s evolving healthcare landscape.

Medically Integrated Dispensing

The use of oral chemotherapy drugs in cancer treatment is increasing at a rapid pace. We provide a comprehensive physician dispensing solution so you can provide the convenience of in-office dispensing to your patients. We combine robust pharmacy technology, managed care expertise, expert pharmacy and clinical support, and comprehensive drug and supply fulfillment to help your practice deliver a better, more comprehensive care experience to put you in control of the oral treatment process.


Integrated Cancer Patient Care

Providing integrated, seamless care under one roof drives better outcomes and increases patient and physician satisfaction, but building a successful multidisciplinary practice is not an easy task. We have a strong history of success in developing integrated oncology practices utilizing a variety of business models. We are committed to enhancing the opportunities for all physicians in The Network to offer integrated value-based cancer care to their patients.


Innovative Technologies

We offer a full range of integrated technology solutions that enable practices to provide patient-focused value-based care. These user-friendly advanced solutions are designed to reduce physician time spent documenting care, freeing up more time for physicians to do what they do best―provide high-quality cancer patient care.

Patient Portal

Oncology patient portal to help patients more efficiently communicate with their care team, enhancing the patient/provider relationship and enabling patients to take a more active role in their care

Learn More

Electronic Health Record (EHR)

Electronic health record equipped for value-based care delivery, providing physicians with complete and accurate information to thoroughly assess a patient’s condition, diagnose problems sooner, prevent errors and support optimal outcomes

Learn More

Clinical Decision Support

Clinical decision support to help ensure patients are receiving the most effective treatments

Learn More

Analytics Engine

Analytics engine to drive value-based care and identify areas where care can be improved

Learn More

Drug Inventory Management

Drug inventory management to help ensure timely access to life saving drugs for patients

Learn More

Excellence in Cancer Care has a Network

As a national network of multi-specialty industry peers, we are dedicated to bringing innovation to local oncology care. We have the backing and resources to offer practices access to capital for expansion, innovative clinical trials through Sarah Cannon Research Institute, and the purchasing power and best-in-class contracting capabilities of Unity Group Purchasing Organization.

Join Our Network

Learn more about our commitment to enabling better cancer care through an integrated and supportive network that helps local practices maintain their independence and prosper.